They also found that COL11A1 expression increased during ovarian cancer progression, and downregulation of COL11A1 in ovarian cancer cells could significantly inhibit tumor growth in vivo (Cheon et al., 2014). This evidence concerns the gene COL11A1 and neoplasm.